Emerging Applications of Artificial Intelligence in the Development of Solid Dosage Forms

Solid dosage forms are the most commonly used pharmaceutical formulations and include tablets, capsules, powders, and granules. These dosage forms consist of active pharmaceutical ingredients (APIs) combined with excipients such as binders, disintegrants, stabilizers, lubricants, antioxidants, and granulating agents [1]. Their widespread use is attributed to advantages such as stability, convenience, accurate dosing, and patient compliance.

The development of solid dosage forms involves several stages, including preformulation studies, formulation design, and manufacturing scale-up. During preformulation, critical physicochemical properties such as solubility, polymorphism, and stability are evaluated. Formulation development focuses on optimizing excipient combinations and processing parameters, while manufacturing ensures reproducibility and scalability.

However, formulation development is associated with multiple challenges. Poor aqueous solubility is a major concern, particularly for drugs belonging to Biopharmaceutical Classification System (BCS) Class II and IV. Approximately 90% of drugs under development exhibit low solubility, resulting in poor bioavailability. Other issues include poor powder flowability [7], narrow therapeutic index [8], and chemical degradation during processing.

Traditional formulation approaches rely heavily on trial-and-error methods, which are time-consuming and resource-intensive. In this context, Artificial Intelligence (AI) has emerged as a promising solution. AI enables predictive modeling, optimization of formulation variables, and improved understanding of complex systems, thereby reducing experimental workload and accelerating development .[2,3]

2. Overview of Artificial Intelligence in Pharmaceutical Sciences

Artificial Intelligence refers to computational techniques that enable machines to mimic human intelligence, including learning, reasoning, and decision-making. In pharmaceutical sciences, AI primarily involves machine learning (ML), deep learning (DL), and neural networks. [4]

Machine learning algorithms analyze historical data to identify patterns and make predictions. Supervised learning methods are commonly used for predicting formulation outcomes, while unsupervised learning techniques help in clustering and pattern recognition. Deep learning, a subset of machine learning, uses multilayer neural networks to model complex nonlinear relationships. [6]

Artificial Neural Networks (ANNs) are widely used in formulation development due to their ability to capture nonlinear interactions between variables. These models are particularly useful in predicting dissolution profiles, bioavailability, and stability. [5]

AI has traditionally been applied in drug discovery for target identification and molecular design. However, its application in formulation development is rapidly growing. Pharmaceutical companies are increasingly collaborating with AI firms to accelerate drug development, optimize formulations, and improve manufacturing efficiency.

3. Regulatory Perspective

The adoption of AI in pharmaceutical development requires compliance with regulatory guidelines established by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Quality by Design (QbD) is a systematic approach that emphasizes understanding of formulation and process variables. AI aligns well with QbD by enabling identification of Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs). [6]

Regulatory agencies emphasize the importance of model validation, transparency, and reproducibility. AI models must be validated using appropriate statistical methods to ensure accuracy and reliability. However, the “black-box” nature of some AI models poses challenges in terms of interpretability, which is a key concern for regulatory approval.

4. Database Creation for AI Models

The success of AI models depends on the availability of high-quality data. Data for pharmaceutical applications can be obtained from experimental studies, scientific literature, and Process Analytical Technology (PAT) systems.

Key variables include API properties such as solubility and polymorphism, excipient characteristics, and process parameters such as compression force and mixing time [7]. The integration of these variables into a structured database enables effective model training.

However, challenges such as data inconsistency, missing values, and lack of standardization can affect model performance. Therefore, careful data curation and validation are essential.

5. Data Processing and Preparation

Data pre-processing is a critical step in AI model development. It involves data cleaning, feature selection, normalization, and transformation.

Data cleaning includes removal of outliers and handling of missing values. Feature engineering involves selecting relevant variables that significantly influence formulation outcomes. Normalization ensures that all variables are on a comparable scale, which improves model performance. [8]

Dimensionality reduction techniques such as Principal Component Analysis (PCA) are used to reduce complexity while retaining important information.

6. AI Algorithms in Formulation Development

Artificial intelligence tools from Machine Learning are increasingly used in pharmaceutical formulation to model complex relationships, optimize compositions, and improve prediction accuracy. Different algorithms offer distinct advantages depending on the data and application.

Artificial Neural Networks (ANN)

ANNs are powerful models capable of capturing nonlinear relationships between formulation variables and responses. They are widely used for dissolution prediction, drug release modelling, and formulation optimization.
 Advantages: High accuracy, handles complex interactions
 Limitations: Requires large datasets, low interpretability (“black-box” nature)

Support Vector Machines (SVM)

SVMs are effective for classification and regression, especially with smaller datasets. They are used in predicting solubility, permeability, and formulation outcomes.
 Advantages: Good generalization, works well with limited data
 Limitations: Computationally intensive, requires careful parameter tuning [9]

Decision Trees and Random Forest

Decision Trees are simple and interpretable models for identifying key formulation factors. Random Forest improves performance by combining multiple trees, reducing overfitting.
 Advantages: Easy to interpret, handles diverse data types
 Limitations: Trees may overfit; Random Forest is less interpretable

Ensemble Methods

Ensemble methods combine predictions from multiple models to improve accuracy and robustness. Techniques include bagging, boosting, and stacking, with methods like AdaBoost and XGBoost widely used.

In pharmaceutics, they enhance prediction of dissolution, stability, and formulation performance.
 Advantages: Higher accuracy, reduced bias and variance
 Limitations: Increased complexity and lower interpretability [10]

Table: Comparison of AI Algorithms